BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29875879)

  • 1. Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel disease.
    Dziaman T; Gackowski D; Guz J; Linowiecka K; Bodnar M; Starczak M; Zarakowska E; Modrzejewska M; Szpila A; Szpotan J; Gawronski M; Labejszo A; Liebert A; Banaszkiewicz Z; Klopocka M; Foksinski M; Marszalek A; Olinski R
    Clin Epigenetics; 2018; 10():72. PubMed ID: 29875879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of Tet-induced oxidation products of 5-methylcytosine in cellular and tissue DNA.
    Liu S; Wang J; Su Y; Guerrero C; Zeng Y; Mitra D; Brooks PJ; Fisher DE; Song H; Wang Y
    Nucleic Acids Res; 2013 Jul; 41(13):6421-9. PubMed ID: 23658232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Measurement of Epigenetic DNA Modifications and 8-oxodG as Possible Noninvasive Markers of Colon Cancer Evolution.
    Skalska-Bugala A; Siomek-Gorecka A; Banaszkiewicz Z; Olinski R; Rozalski R
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease.
    Starczak M; Zarakowska E; Modrzejewska M; Dziaman T; Szpila A; Linowiecka K; Guz J; Szpotan J; Gawronski M; Labejszo A; Liebert A; Banaszkiewicz Z; Klopocka M; Foksinski M; Gackowski D; Olinski R
    J Transl Med; 2018 Jul; 16(1):204. PubMed ID: 30029654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate, Direct, and High-Throughput Analyses of a Broad Spectrum of Endogenously Generated DNA Base Modifications with Isotope-Dilution Two-Dimensional Ultraperformance Liquid Chromatography with Tandem Mass Spectrometry: Possible Clinical Implication.
    Gackowski D; Starczak M; Zarakowska E; Modrzejewska M; Szpila A; Banaszkiewicz Z; Olinski R
    Anal Chem; 2016 Dec; 88(24):12128-12136. PubMed ID: 28193047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of oxidation products of 5-methyl-2'-deoxycytidine in Arabidopsis DNA.
    Liu S; Dunwell TL; Pfeifer GP; Dunwell JM; Ullah I; Wang Y
    PLoS One; 2013; 8(12):e84620. PubMed ID: 24391970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TET enzymes are successively expressed during human spermatogenesis and their expression level is pivotal for male fertility.
    Ni K; Dansranjavin T; Rogenhofer N; Oeztuerk N; Deuker J; Bergmann M; Schuppe HC; Wagenlehner F; Weidner W; Steger K; Schagdarsurengin U
    Hum Reprod; 2016 Jul; 31(7):1411-24. PubMed ID: 27141042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2'-deoxycytidine level in cultured cancerous cell lines.
    Foksinski M; Zarakowska E; Gackowski D; Skonieczna M; Gajda K; Hudy D; Szpila A; Bialkowski K; Starczak M; Labejszo A; Czyz J; Rzeszowska-Wolny J; Olinski R
    PLoS One; 2017; 12(11):e0188856. PubMed ID: 29190698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer.
    Rawłuszko-Wieczorek AA; Siera A; Horbacka K; Horst N; Krokowicz P; Jagodziński PP
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1379-92. PubMed ID: 25557833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-Specific Differences in DNA Modifications (5-Hydroxymethylcytosine, 5-Formylcytosine, 5-Carboxylcytosine and 5-Hydroxymethyluracil) and Their Interrelationships.
    Gackowski D; Zarakowska E; Starczak M; Modrzejewska M; Olinski R
    PLoS One; 2015; 10(12):e0144859. PubMed ID: 26660343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of TET Family Gene Expression and 5-Hydroxymethylcytosine as Potential Epigenetic Markers in Non-small Cell Lung Cancer.
    Alrehaili AA; Gharib AF; Alghamdi SA; Alhazmi A; Al-Shehri SS; Hagag HM; Alsaeedi FA; Alhuthali HM; Raafat N; Etewa RL; Elsawy WH
    In Vivo; 2023; 37(1):445-453. PubMed ID: 36593050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced mRNA and Protein Expression Levels of Tet Methylcytosine Dioxygenase 3 in Endothelial Progenitor Cells of Patients of Type 2 Diabetes With Peripheral Artery Disease.
    Zhao S; Jia T; Tang Y; Zhang X; Mao H; Tian X; Li R; Ma L; Chen G
    Front Immunol; 2018; 9():2859. PubMed ID: 30574144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new methodology to reveal potential nucleic acid modifications associated with the risk of endometrial cancer through dispersive solid-phase extraction coupled with UHPLC-QE-Orbitrap-MS/MS and HPLC-UV.
    Zhao H; Zhang X; Zuo L; Li L; Yang H; Zhang M; Wang N; Jia Q; Liu Y
    Anal Bioanal Chem; 2024 Apr; 416(10):2439-2452. PubMed ID: 38400939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of an Active Deformylation Mechanism of 5-Formyl-deoxycytidine (fdC) in Stem Cells.
    Schön A; Kaminska E; Schelter F; Ponkkonen E; Korytiaková E; Schiffers S; Carell T
    Angew Chem Int Ed Engl; 2020 Mar; 59(14):5591-5594. PubMed ID: 31999041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TET proteins and epigenetic modifications in cancers].
    Ciesielski P; Jóźwiak P; Krześlak A
    Postepy Hig Med Dosw (Online); 2015 Dec; 69():1371-83. PubMed ID: 26671928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxymethyl-, 5-Formyl- and 5-Carboxydeoxycytidines as Oxidative Lesions and Epigenetic Marks.
    Schelter F; Kirchner A; Traube FR; Müller M; Steglich W; Carell T
    Chemistry; 2021 Jun; 27(31):8100-8104. PubMed ID: 33769637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
    Du C; Kurabe N; Matsushima Y; Suzuki M; Kahyo T; Ohnishi I; Tanioka F; Tajima S; Goto M; Yamada H; Tao H; Shinmura K; Konno H; Sugimura H
    Gastric Cancer; 2015 Jul; 18(3):516-25. PubMed ID: 25098926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways.
    Noreen F; Küng T; Tornillo L; Parker H; Silva M; Weis S; Marra G; Rad R; Truninger K; Schär P
    Clin Epigenetics; 2019 Dec; 11(1):196. PubMed ID: 31842975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype.
    Tricarico R; Madzo J; Scher G; Cohen M; Jelinek J; Maegawa S; Nagarathinam R; Scher C; Chang WC; Nicolas E; Slifker M; Zhou Y; Devarajan K; Cai KQ; Kwok T; Nakajima P; Xu J; Mancuso P; Doneddu V; Bagella L; Williams R; Balachandran S; Maskalenko N; Campbell K; Ma X; Cañadas I; Viana-Errasti J; Moreno V; Valle L; Grivennikov S; Peshkova I; Kurilenko N; Mazitova A; Koltsova E; Lee H; Walsh M; Duttweiler R; Whetstine JR; Yen TJ; Issa JP; Bellacosa A
    Gastroenterology; 2023 May; 164(6):921-936.e1. PubMed ID: 36764492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are 8-oxoguanine (8-oxoGua) and 5-hydroxymethyluracil (5-hmUra) oxidatively damaged DNA bases or transcription (epigenetic) marks?
    Zarakowska E; Gackowski D; Foksinski M; Olinski R
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Apr; 764-765():58-63. PubMed ID: 24055867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.